Mortality rates at 494 hospitals around the country that participated in clinical trials for acute coronary syndrome declined, according to Modern Healthcare. Of 174,062 patients treated, only 3.5 percent died in hospitals that practiced what was deemed a "high level of clinical activity." For hospitals that had never participated in such trials, 5.9 percent of those patients died. "The facilities were chosen for the study because they are part of a voluntary quality initiative dubbed 'Crusade,' which is trying to reduce adverse events among unstable angina patients using American College of Cardiology/American Heart Association guidelines," the article said.
For more information:
- read the Modern Healthcare article
Related Articles:
Cancer patients take front line in early-stage trials. Report
Bill forbids coverage denial during clinical trials. Article
Clinical trials registry legislation proposed. Article